Immix Biopharma Inc. Common Stock is a biotechnology company that develops novel cancer therapeutics using its proprietary antibody-drug conjugate platform. With a focus on targeting solid tumors, the company’s innovative approach holds promise for improved treatment outcomes and enhanced patient well-being. #biotech #cancerresearch
